Novel Compound Demonstrates Activity Against Vancomycin-Resistant Enterococci
Fighting Antibiotic Resistance: The Promising Potential of V-161 Vancomycin-Resistant Enterococcus (VRE) has been a formidable challenge in hospital-acquired infections, causing severe conditions like endocarditis and sepsis. Recent breakthroughs from Japan suggest a novel compound, V-161, might change the future of how we tackle these resilient bacteria. The CDC highlights that VRE infections result in thousands … Read more